Recent Advances in Cellular and Non-Cellular Treatment of Stroke
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: 31 May 2025 | Viewed by 746
Special Issue Editor
Interests: stem cells; regenerative medicine; tissue engineering; cancer; umbilical cord blood and tissue; adipose-derived stem cells; aging
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Stroke occurs when the blood flow to the brain is interrupted due to a rupture of blood vessels or a blockage in the brain, and it is a major cause of physical disability in adulthood. Despite advances in surgical and pharmacological therapy, functional recovery from stroke is limited, affecting the quality of life of patients. Biomolecules such as tPA have shown some benefits and other approaches are being developed. Stem cell therapy, which may treat neurological disorders associated with brain traumas including stroke is an important focus of stroke research and treatment. Stem cell therapy has primarily used a type of adult stem cells called mesenchymal stem cells (MSCs) due to their ability to develop into multiple lineages in order to regenerate brain cells, release active biomolecules, and repair brain tissues. A significant number of clinical studies have provided evidence of the potential of MSCs to treat stroke. This review will summarize the therapeutic mechanisms of stroke treatment and we also seeks to highlight the current challenges and future prospects of adult therapy for stroke treatment.
Prof. Dr. David T. Harris
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- stroke
- treatment
- therapy
- biomolecules
- stem cells
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
